Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) EBIT Margin (2016 - 2025)

Orthofix Medical (OFIX) has disclosed EBIT Margin for 16 consecutive years, with 0.29% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin fell 1825.0% year-over-year to 0.29%, compared with a TTM value of 10.5% through Dec 2025, down 735.0%, and an annual FY2025 reading of 10.5%, down 725.0% over the prior year.
  • EBIT Margin was 0.29% for Q4 2025 at Orthofix Medical, up from 7.43% in the prior quarter.
  • Across five years, EBIT Margin topped out at 37.38% in Q4 2023 and bottomed at 34.08% in Q1 2023.
  • Average EBIT Margin over 5 years is 5.18%, with a median of 4.63% recorded in 2021.
  • Peak annual rise in EBIT Margin hit 3961bps in 2023, while the deepest fall reached -3119bps in 2023.
  • Year by year, EBIT Margin stood at 3.51% in 2021, then skyrocketed by 36bps to 2.23% in 2022, then skyrocketed by 1775bps to 37.38% in 2023, then tumbled by -50bps to 18.54% in 2024, then crashed by -98bps to 0.29% in 2025.
  • Business Quant data shows EBIT Margin for OFIX at 0.29% in Q4 2025, 7.43% in Q3 2025, and 8.36% in Q2 2025.